LOPINAVIR AND RITONAVIR

LOPINAVIR AND RITONAVIR was reported 13487 times

LOPINAVIR AND RITONAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC DISPLACEMENT 16 0.6667
1 DIAPHRAGMATIC APLASIA 17 0.6538
2 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 82 0.6357
3 ULTRASOUND ANTENATAL SCREEN 53 0.5521
4 HIV WASTING SYNDROME 15 0.4167
5 SPINOCEREBELLAR DISORDER 17 0.3617
6 TOTAL LUNG CAPACITY INCREASED 97 0.3566
7 AIDS ENCEPHALOPATHY 20 0.3448
8 CARDIAC MALPOSITION 23 0.3026
9 CONGENITAL HEPATOBILIARY ANOMALY 9 0.2647
10 CONGENITAL DIAPHRAGMATIC ANOMALY 9 0.2500
11 MITOCHONDRIAL TOXICITY 177 0.2156
12 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 97 0.1855
13 HIV ASSOCIATED NEPHROPATHY 9 0.1765
14 ALPHA 1 FOETOPROTEIN ABNORMAL 15 0.1500
15 AIDS DEMENTIA COMPLEX 9 0.1475
16 TRISOMY 18 52 0.1365
17 LIPODYSTROPHY ACQUIRED 290 0.1365
18 IMMUNE RECONSTITUTION SYNDROME 137 0.1061
19 NEURODEVELOPMENTAL DISORDER 64 0.0947
20 BONE DEMINERALISATION 97 0.0916
21 KAPOSI'S SARCOMA 42 0.0837
22 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 9 0.0811
23 ERGOT POISONING 10 0.0800
24 CUSHING'S SYNDROME 55 0.0791
25 DEFORMITY THORAX 15 0.0777
26 ACQUIRED IMMUNODEFICIENCY SYNDROME 40 0.0771
27 BURKITT'S LYMPHOMA 8 0.0762
28 RICKETS 14 0.0741
29 PNEUMOCYSTIS CARINII PNEUMONIA 15 0.0739
30 MITOCHONDRIAL CYTOPATHY 31 0.0705
31 PORTAL FIBROSIS 15 0.0701
32 FANCONI SYNDROME ACQUIRED 121 0.0689
33 ULTRASOUND ANTENATAL SCREEN ABNORMAL 15 0.0682
34 CONGENITAL HEARING DISORDER 11 0.0679
35 ADRENOGENITAL SYNDROME 9 0.0667
36 CEREBELLAR HYPOPLASIA 11 0.0655
37 HYDROPS FOETALIS 40 0.0653
38 PSYCHIATRIC DECOMPENSATION 120 0.0613
39 TRISOMY 21 73 0.0579
40 CD4 LYMPHOCYTES ABNORMAL 12 0.0571
41 DOUBLE OUTLET RIGHT VENTRICLE 15 0.0508
42 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 14 0.0504
43 EXOMPHALOS 26 0.0484
44 POLYDACTYLY 56 0.0483
45 JAUNDICE CHOLESTATIC 170 0.0481
46 HYPOMANIA 174 0.0473
47 SKULL MALFORMATION 30 0.0467
48 PSYCHOMOTOR SKILLS IMPAIRED 117 0.0446
49 ENCEPHALOCELE 11 0.0442
50 CD4 LYMPHOCYTES INCREASED 10 0.0429
51 CONGENITAL CHOROID PLEXUS CYST 13 0.0426
52 DANDY-WALKER SYNDROME 11 0.0425
53 STILLBIRTH 203 0.0420
54 CLEFT LIP AND PALATE 46 0.0411
55 PLACENTAL INFARCTION 9 0.0404
56 KIDNEY MALFORMATION 14 0.0398
57 FANCONI SYNDROME 56 0.0396
58 LOW SET EARS 16 0.0389
59 INTRA-UTERINE DEATH 62 0.0386
60 FACIAL WASTING 10 0.0372
61 CEREBRAL TOXOPLASMOSIS 34 0.0364
62 LIPOATROPHY 34 0.0357
63 OPHTHALMOPLEGIA 56 0.0355
64 CHRONIC HEPATITIS C 14 0.0354
65 MENINGOMYELOCELE 21 0.0350
66 FOETAL CARDIAC DISORDER 11 0.0348
67 HYPERFERRITINAEMIA 15 0.0348
68 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 8 0.0343
69 DEPRESSION SUICIDAL 117 0.0338
70 FOETAL ARRHYTHMIA 9 0.0335
71 CONGENITAL SKIN DIMPLES 8 0.0332
72 DEPRESSIVE SYMPTOM 117 0.0332
73 CEREBRAL VENTRICLE DILATATION 38 0.0330
74 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
75 RENAL TUBULAR DISORDER 92 0.0327
76 PORPHYRIA NON-ACUTE 14 0.0322
77 PLAGIOCEPHALY 16 0.0321
78 CONGENITAL HYDROCEPHALUS 16 0.0316
79 HYPOURICAEMIA 9 0.0310
80 CHOLESTASIS OF PREGNANCY 14 0.0304
81 CONGENITAL NOSE MALFORMATION 16 0.0301
82 FOETAL GROWTH RETARDATION 23 0.0294
83 CLINODACTYLY 8 0.0291
84 LIPOHYPERTROPHY 18 0.0289
85 PLACENTAL DISORDER 27 0.0285
86 TEARFULNESS 122 0.0283
87 BLIGHTED OVUM 11 0.0280
88 CD4 LYMPHOCYTES DECREASED 59 0.0275
89 NEURAL TUBE DEFECT 20 0.0275
90 NEONATAL ASPIRATION 9 0.0274
91 ANENCEPHALY 15 0.0265
92 PLACENTAL INSUFFICIENCY 21 0.0262
93 HIV INFECTION 78 0.0259
94 CRYPTORCHISM 29 0.0258
95 ANOGENITAL WARTS 23 0.0258
96 PREMATURE RUPTURE OF MEMBRANES 62 0.0257
97 HYPERTRIGLYCERIDAEMIA 146 0.0249
98 SYPHILIS 18 0.0248
99 OSTEOMALACIA 38 0.0246
100 OESOPHAGEAL ATRESIA 15 0.0240
101 SPINA BIFIDA 50 0.0240
102 GENOTYPE DRUG RESISTANCE TEST POSITIVE 24 0.0233
103 LONG QT SYNDROME 56 0.0233
104 RHINITIS ALLERGIC 103 0.0231
105 GASTROSCHISIS 11 0.0231
106 HYPERLACTACIDAEMIA 62 0.0231
107 GLYCOSURIA 31 0.0229
108 PLACENTA PRAEVIA 18 0.0229
109 DRUG EXPOSURE DURING PREGNANCY 778 0.0228
110 VIRAL LOAD INCREASED 88 0.0226
111 VIROLOGIC FAILURE 119 0.0221
112 SARCOIDOSIS 100 0.0210
113 PYELOCALIECTASIS 20 0.0209
114 UMBILICAL CORD ABNORMALITY 11 0.0209
115 ANAEMIA NEONATAL 10 0.0207
116 BLOOD HIV RNA INCREASED 37 0.0204
117 ABORTION INDUCED 192 0.0204
118 TOXOPLASMOSIS 22 0.0204
119 BLOOD CORTISOL DECREASED 13 0.0203
120 MICROCEPHALY 26 0.0203
121 ARNOLD-CHIARI MALFORMATION 19 0.0199
122 FOLATE DEFICIENCY 23 0.0199
123 RENAL TUBULAR ACIDOSIS 43 0.0197
124 NASAL POLYPS 97 0.0197
125 COARCTATION OF THE AORTA 19 0.0197
126 HELLP SYNDROME 12 0.0196
127 ANHEDONIA 510 0.0194
128 ATRIOVENTRICULAR SEPTAL DEFECT 9 0.0191
129 VOLVULUS 45 0.0190
130 SCHIZOPHRENIA 230 0.0189
131 PNEUMOCYSTIS JIROVECI PNEUMONIA 42 0.0188
132 CONGENITAL MUSCULOSKELETAL ANOMALY 8 0.0181
133 CYTOLYTIC HEPATITIS 59 0.0178
134 MENINGITIS CRYPTOCOCCAL 31 0.0177
135 POLYHYDRAMNIOS 18 0.0176
136 CYTOMEGALOVIRUS CHORIORETINITIS 34 0.0174
137 CARDIAC MURMUR 150 0.0173
138 EYELID PTOSIS 176 0.0173
139 EAR MALFORMATION 8 0.0173
140 DYSMORPHISM 40 0.0170
141 HODGKIN'S DISEASE 12 0.0166
142 PREMATURE LABOUR 91 0.0161
143 FAT TISSUE INCREASED 23 0.0159
144 MYCOBACTERIUM AVIUM COMPLEX INFECTION 42 0.0156
145 FOETAL DISORDER 13 0.0156
146 NEONATAL ASPHYXIA 11 0.0155
147 ANAL CANCER 15 0.0155
148 CONGENITAL HYDRONEPHROSIS 11 0.0154
149 VISCERAL LEISHMANIASIS 11 0.0152
150 BLOOD AMYLASE INCREASED 26 0.0152
151 SUPERINFECTION BACTERIAL 12 0.0151
152 BLOOD LACTIC ACID INCREASED 78 0.0148
153 DYSLIPIDAEMIA 74 0.0146
154 CHLAMYDIAL INFECTION 11 0.0146
155 BRONCHIECTASIS 98 0.0145
156 ADRENAL SUPPRESSION 12 0.0142
157 ATYPICAL MYCOBACTERIAL INFECTION 20 0.0141
158 OSTEOPENIA 214 0.0141
159 TRANSPOSITION OF THE GREAT VESSELS 11 0.0140
160 FOETAL HEART RATE ABNORMAL 13 0.0140
161 NODULAR REGENERATIVE HYPERPLASIA 9 0.0140
162 ECONOMIC PROBLEM 211 0.0139
163 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 15 0.0139
164 PREMATURE SEPARATION OF PLACENTA 21 0.0136
165 NEPHRITIS INTERSTITIAL 17 0.0134
166 VENTRICULAR SEPTAL DEFECT 76 0.0133
167 HEPATOSPLENOMEGALY 34 0.0132
168 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 66 0.0132
169 T-LYMPHOCYTE COUNT DECREASED 9 0.0132
170 SKELETAL INJURY 135 0.0130
171 VIRAL MUTATION IDENTIFIED 48 0.0130
172 NON-HODGKIN'S LYMPHOMA 17 0.0130
173 DEATH NEONATAL 18 0.0129
174 FOETAL DISTRESS SYNDROME 27 0.0127
175 PULMONARY VALVE STENOSIS 10 0.0125
176 SICK SINUS SYNDROME 14 0.0122
177 LYMPH NODE TUBERCULOSIS 9 0.0121
178 OSTEOPOROTIC FRACTURE 23 0.0120
179 TWIN PREGNANCY 10 0.0119
180 TALIPES 36 0.0116
181 CYTOGENETIC ABNORMALITY 13 0.0115
182 MATERNAL DRUGS AFFECTING FOETUS 88 0.0115
183 LIVE BIRTH 96 0.0115
184 CAESAREAN SECTION 133 0.0114
185 PREMATURE BABY 342 0.0114
186 MULTIPLE-DRUG RESISTANCE 35 0.0113
187 ALPHA 1 FOETOPROTEIN INCREASED 8 0.0112
188 FOETAL DEATH 58 0.0112
189 BLOOD BILIRUBIN INCREASED 299 0.0111
190 FOETAL MALFORMATION 12 0.0110
191 HEPATOTOXICITY 246 0.0110
192 BONE LOSS 166 0.0110
193 BONE DENSITY DECREASED 335 0.0107
194 ABORTION SPONTANEOUS 428 0.0107
195 SMALL FOR DATES BABY 53 0.0107
196 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 35 0.0106
197 CONGENITAL ANOMALY 82 0.0106
198 OESOPHAGEAL CANDIDIASIS 42 0.0105
199 CYSTITIS NONINFECTIVE 14 0.0104
200 NEPHROGENIC DIABETES INSIPIDUS 12 0.0104
201 PSYCHOTIC DISORDER 306 0.0104
202 CACHEXIA 51 0.0099
203 PATENT DUCTUS ARTERIOSUS 39 0.0098
204 NORMAL NEWBORN 53 0.0097
205 MULTIPLE FRACTURES 160 0.0097
206 OPPORTUNISTIC INFECTION 18 0.0097
207 PORTAL HYPERTENSION 30 0.0097
208 OSTEOPOROSIS 400 0.0097
209 PRE-ECLAMPSIA 46 0.0097
210 FUNGAL SEPSIS 8 0.0096
211 HYPOSPADIAS 20 0.0096
212 PULMONARY TUBERCULOSIS 41 0.0096
213 VARICES OESOPHAGEAL 29 0.0096
214 NEONATAL DISORDER 15 0.0095
215 BRAIN HERNIATION 28 0.0094
216 HYPERTRANSAMINASAEMIA 65 0.0093
217 FOETAL EXPOSURE DURING PREGNANCY 757 0.0093
218 FOETAL GROWTH RESTRICTION 56 0.0092
219 CRYPTOCOCCOSIS 15 0.0092
220 HYPERBILIRUBINAEMIA 95 0.0092
221 BLOOD BICARBONATE DECREASED 17 0.0090
222 HYPOPHOSPHATAEMIA 66 0.0089
223 BLOOD ALKALINE PHOSPHATASE ABNORMAL 8 0.0089
224 DRUG EXPOSURE BEFORE PREGNANCY 9 0.0089
225 DRUG INTERACTION 1338 0.0084
226 MECHANICAL VENTILATION 16 0.0084
227 BLOOD PHOSPHORUS DECREASED 30 0.0082
228 PSYCHOMOTOR RETARDATION 23 0.0082
229 OLIGOHYDRAMNIOS 27 0.0081
230 HEPATITIS FULMINANT 24 0.0081
231 CENTRAL NERVOUS SYSTEM LYMPHOMA 11 0.0080
232 LYMPHOCYTIC INFILTRATION 8 0.0079
233 LIP DISCOLOURATION 10 0.0079
234 CHOLELITHIASIS 259 0.0079
235 HYDROCEPHALUS 43 0.0079
236 GLUCOSE URINE PRESENT 10 0.0079
237 LUNG NEOPLASM 33 0.0077
238 BILIRUBIN CONJUGATED INCREASED 18 0.0077
239 FAECES PALE 17 0.0076
240 OSTEONECROSIS 251 0.0076
241 HEPATITIS CHOLESTATIC 46 0.0076
242 HEPATOCELLULAR INJURY 108 0.0076
243 ENDOTRACHEAL INTUBATION 21 0.0075
244 PNEUMONIA PNEUMOCOCCAL 11 0.0074
245 MIXED LIVER INJURY 22 0.0073
246 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 348 0.0072
247 BREECH PRESENTATION 9 0.0071
248 CALCULUS URINARY 11 0.0071
249 OCULAR ICTERUS 31 0.0071
250 ABORTION MISSED 9 0.0071
251 PARANOIA 122 0.0071
252 ANAEMIA MACROCYTIC 15 0.0070
253 HYPERLIPIDAEMIA 84 0.0070
254 CARBON DIOXIDE DECREASED 8 0.0069
255 LIPIDS INCREASED 14 0.0069
256 RENAL FAILURE ACUTE 293 0.0069
257 BLOOD TRIGLYCERIDES INCREASED 121 0.0068
258 DIPLOPIA 175 0.0067
259 HEPATOMEGALY 66 0.0067
260 PREGNANCY 132 0.0066
261 NEPHROPATHY 61 0.0065
262 GESTATIONAL DIABETES 31 0.0065
263 BACTERIAL SEPSIS 21 0.0064
264 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 8 0.0063
265 RADIUS FRACTURE 15 0.0062
266 ATRIAL SEPTAL DEFECT 52 0.0062
267 RENAL COLIC 14 0.0062
268 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0062
269 PROTEINURIA 115 0.0060
270 END STAGE RENAL DISEASE 110 0.0060
271 RENAL TUBULAR NECROSIS 59 0.0060
272 BENIGN PROSTATIC HYPERPLASIA 31 0.0060
273 NEONATAL RESPIRATORY DISTRESS SYNDROME 21 0.0059
274 CUSHINGOID 19 0.0059
275 ECTOPIC PREGNANCY 18 0.0058
276 PARESIS 13 0.0058
277 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 48 0.0058
278 HEPATOCELLULAR DAMAGE 13 0.0058
279 RENAL INJURY 170 0.0057
280 IDIOPATHIC THROMBOCYTOPENIC PURPURA 9 0.0057
281 CLEFT PALATE 11 0.0057
282 CHRONIC KIDNEY DISEASE 431 0.0057
283 HEART DISEASE CONGENITAL 20 0.0056
284 BRONCHOPNEUMONIA 19 0.0055
285 CELL DEATH 11 0.0055
286 ACUTE ABDOMEN 8 0.0054
287 HEPATIC CYTOLYSIS 69 0.0054
288 LOBAR PNEUMONIA 10 0.0054
289 PATHOGEN RESISTANCE 49 0.0054
290 GAMMA-GLUTAMYLTRANSFERASE INCREASED 118 0.0053
291 TOOTH LOSS 110 0.0053
292 ABDOMINAL HERNIA 24 0.0053
293 ACIDOSIS 40 0.0052
294 ALANINE AMINOTRANSFERASE ABNORMAL 11 0.0052
295 BLOOD ALKALINE PHOSPHATASE INCREASED 127 0.0051
296 CHOLESTASIS 98 0.0051
297 POLYDIPSIA 20 0.0051
298 GENE MUTATION 10 0.0050
299 MEDICATION RESIDUE 13 0.0050
300 DEPRESSION 1141 0.0050
301 EXPOSURE DURING PREGNANCY 310 0.0050
302 CANDIDIASIS 20 0.0050
303 DIABETES INSIPIDUS 12 0.0050
304 ENCEPHALITIS 34 0.0049
305 LOW BIRTH WEIGHT BABY 39 0.0049
306 DRUG RESISTANCE 125 0.0049
307 PROTEIN URINE PRESENT 24 0.0048
308 ANOREXIA 62 0.0048
309 ASPARTATE AMINOTRANSFERASE INCREASED 254 0.0048
310 HEPATIC NECROSIS 18 0.0048
311 EMOTIONAL DISTRESS 578 0.0048
312 ORAL CANDIDIASIS 62 0.0047
313 HYPERURICAEMIA 19 0.0046
314 HYPOVOLAEMIC SHOCK 22 0.0046
315 NEPHROPATHY TOXIC 51 0.0045
316 LYMPHADENITIS 11 0.0045
317 DECREASED ACTIVITY 49 0.0045
318 HEPATITIS 116 0.0045
319 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
320 STAPHYLOCOCCAL SEPSIS 22 0.0045
321 HEPATIC CIRRHOSIS 83 0.0044
322 QUALITY OF LIFE DECREASED 59 0.0044
323 HYPERPARATHYROIDISM SECONDARY 11 0.0044
324 HAND FRACTURE 31 0.0044
325 HEPATITIS C 52 0.0043
326 FEMORAL NECK FRACTURE 22 0.0043
327 PATELLA FRACTURE 10 0.0043
328 DILATATION VENTRICULAR 9 0.0043
329 HEPATIC NEOPLASM MALIGNANT 9 0.0042
330 FIBROSIS 13 0.0042
331 JAUNDICE 113 0.0042
332 ALANINE AMINOTRANSFERASE INCREASED 257 0.0042
333 TRANSAMINASES INCREASED 93 0.0042
334 LIPASE INCREASED 32 0.0042
335 ORAL INTAKE REDUCED 10 0.0041
336 CONGESTIVE CARDIOMYOPATHY 17 0.0041
337 RENAL FAILURE 540 0.0041
338 DRUG TOXICITY 55 0.0040
339 PSEUDOMEMBRANOUS COLITIS 9 0.0040
340 ACUTE PULMONARY OEDEMA 22 0.0039
341 RENAL FAILURE CHRONIC 30 0.0039
342 APHTHOUS STOMATITIS 9 0.0039
343 CEREBRAL ISCHAEMIA 20 0.0039
344 SPLENOMEGALY 45 0.0038
345 ILEUS PARALYTIC 17 0.0038
346 METABOLIC ACIDOSIS 121 0.0038
347 ATRIOVENTRICULAR BLOCK COMPLETE 25 0.0037
348 HYPERCHOLESTEROLAEMIA 36 0.0037
349 CAROTID ARTERY STENOSIS 13 0.0037
350 BLOOD CREATININE INCREASED 242 0.0037
351 HISTIOCYTOSIS HAEMATOPHAGIC 11 0.0037
352 VITAMIN D DEFICIENCY 36 0.0037
353 LACTIC ACIDOSIS 119 0.0037
354 CERVICAL DYSPLASIA 8 0.0037
355 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
356 DEVELOPMENTAL DELAY 33 0.0037
357 HEPATITIS B 22 0.0036
358 MULTI-ORGAN FAILURE 63 0.0036
359 RASH MORBILLIFORM 10 0.0036
360 GLUCOSE TOLERANCE IMPAIRED 21 0.0035
361 MATERNAL EXPOSURE DURING PREGNANCY 315 0.0035
362 SUDDEN CARDIAC DEATH 12 0.0035
363 GUILLAIN-BARRE SYNDROME 17 0.0035
364 HEPATIC ENZYME INCREASED 238 0.0035
365 ANURIA 30 0.0035
366 HEPATIC FAILURE 104 0.0034
367 BLOOD CREATINE INCREASED 15 0.0034
368 CHOLANGITIS 21 0.0034
369 PROTEIN TOTAL INCREASED 9 0.0034
370 LOW DENSITY LIPOPROTEIN INCREASED 26 0.0034
371 HAEMODIALYSIS 28 0.0033
372 HUMERUS FRACTURE 16 0.0033
373 ADRENAL INSUFFICIENCY 40 0.0033
374 ATRIOVENTRICULAR BLOCK SECOND DEGREE 10 0.0033
375 FRACTURE 61 0.0032
376 LUNG CONSOLIDATION 9 0.0032
377 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
378 RENAL IMPAIRMENT 268 0.0032
379 POLYURIA 26 0.0032
380 WRIST FRACTURE 38 0.0032
381 PANCYTOPENIA 176 0.0031
382 SPINAL COMPRESSION FRACTURE 26 0.0031
383 PREMATURE DELIVERY 50 0.0031
384 FOOT FRACTURE 59 0.0031
385 PORTAL VEIN THROMBOSIS 10 0.0031
386 BILIARY COLIC 9 0.0031
387 HAEMORRHAGIC DIATHESIS 11 0.0031
388 NEPHROTIC SYNDROME 21 0.0031
389 STRABISMUS 9 0.0031
390 PANCREATITIS ACUTE 67 0.0030
391 BONE DENSITY ABNORMAL 11 0.0029
392 TACHYPNOEA 40 0.0029
393 GLOMERULAR FILTRATION RATE DECREASED 36 0.0029
394 HEPATITIS ACUTE 19 0.0029
395 BLOOD LACTATE DEHYDROGENASE INCREASED 46 0.0029
396 HEPATIC ENCEPHALOPATHY 27 0.0029
397 FAILURE TO THRIVE 15 0.0029
398 ACUTE RESPIRATORY DISTRESS SYNDROME 51 0.0029
399 CORONAVIRUS INFECTION 19 0.0029
400 ELECTROENCEPHALOGRAM ABNORMAL 9 0.0028
401 LIVER DISORDER 126 0.0028
402 HYPOALBUMINAEMIA 22 0.0028
403 DRUG LEVEL INCREASED 46 0.0028
404 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
405 PATHOLOGICAL FRACTURE 14 0.0028
406 AZOTAEMIA 11 0.0028
407 CREATININE RENAL CLEARANCE DECREASED 11 0.0027
408 PRESCRIBED OVERDOSE 53 0.0027
409 PNEUMONIA BACTERIAL 25 0.0027
410 LYMPHADENOPATHY 96 0.0027
411 RIB FRACTURE 55 0.0027
412 ANKLE FRACTURE 41 0.0026
413 HEPATIC STEATOSIS 49 0.0026
414 LUMBAR VERTEBRAL FRACTURE 12 0.0026
415 PRIAPISM 9 0.0026
416 HERPES VIRUS INFECTION 15 0.0026
417 BLOOD URIC ACID INCREASED 15 0.0026
418 NEPHROGENIC ANAEMIA 12 0.0026
419 CORONARY ARTERY STENOSIS 13 0.0026
420 HYPERREFLEXIA 9 0.0026
421 RALES 15 0.0026
422 UMBILICAL HERNIA 12 0.0026
423 RHABDOMYOLYSIS 107 0.0026
424 BONE MARROW FAILURE 52 0.0026
425 SUDDEN DEATH 27 0.0025
426 DUODENAL ULCER 18 0.0025
427 NAIL DISCOLOURATION 10 0.0025
428 FACIAL PARESIS 9 0.0025
429 COVID-19 PNEUMONIA 30 0.0025
430 HYDRONEPHROSIS 19 0.0025
431 MACULOPATHY 9 0.0025
432 ODYNOPHAGIA 15 0.0025
433 INTRACRANIAL PRESSURE INCREASED 14 0.0025
434 CEREBRAL ATROPHY 10 0.0025
435 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
436 ANXIETY 712 0.0025
437 HEPATIC FUNCTION ABNORMAL 93 0.0025
438 RENAL TRANSPLANT 9 0.0025
439 ASCITES 73 0.0025
440 BLOOD CREATINE PHOSPHOKINASE INCREASED 71 0.0025
441 INGUINAL HERNIA 15 0.0025
442 PYELONEPHRITIS 21 0.0024
443 OLIGURIA 15 0.0024
444 LUNG NEOPLASM MALIGNANT 98 0.0024
445 SLEEP TERROR 10 0.0024
446 ANAEMIA 452 0.0024
447 AGRANULOCYTOSIS 44 0.0024
448 TIBIA FRACTURE 11 0.0023
449 SHOCK HAEMORRHAGIC 19 0.0023
450 DIFFICULTY IN WALKING 8 0.0023
451 RESPIRATORY DISTRESS 64 0.0023
452 GRANULOMA 8 0.0023
453 ANGINA UNSTABLE 15 0.0023
454 ELECTROCARDIOGRAM QT PROLONGED 83 0.0023
455 LIVER FUNCTION TEST ABNORMAL 67 0.0023
456 FAECAL INCONTINENCE 11 0.0023
457 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 119 0.0023
458 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39 0.0023
459 NYSTAGMUS 12 0.0023
460 HAEMOLYSIS 17 0.0022
461 GASTROENTERITIS 32 0.0022
462 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
463 PROTHROMBIN TIME PROLONGED 13 0.0022
464 LYMPHOEDEMA 15 0.0022
465 ELECTROCARDIOGRAM ABNORMAL 17 0.0022
466 LEUKOENCEPHALOPATHY 8 0.0021
467 TREATMENT NONCOMPLIANCE 117 0.0021
468 LYMPHOMA 33 0.0021
469 LYMPHOPENIA 30 0.0021
470 HAEMOLYTIC ANAEMIA 19 0.0021
471 AUTOIMMUNE THYROIDITIS 8 0.0021
472 RASH MACULO-PAPULAR 47 0.0021
473 MALABSORPTION 11 0.0021
474 MENINGITIS 14 0.0021
475 POLYNEUROPATHY 25 0.0021
476 RENAL PAIN 22 0.0021
477 GENERAL PHYSICAL CONDITION ABNORMAL 14 0.0021
478 GRAND MAL CONVULSION 19 0.0021
479 STRESS FRACTURE 11 0.0020
480 TUBULOINTERSTITIAL NEPHRITIS 38 0.0020
481 HYPOKALAEMIA 93 0.0020
482 RENAL CYST 16 0.0020
483 HYPOTONIA 20 0.0020
484 COAGULOPATHY 33 0.0020
485 PANCREATITIS 103 0.0019
486 EXERCISE TOLERANCE DECREASED 11 0.0019
487 HAEMATURIA 65 0.0019
488 METABOLIC DISORDER 11 0.0019
489 TOXIC SKIN ERUPTION 19 0.0019
490 ALCOHOLISM 8 0.0019
491 CYTOMEGALOVIRUS INFECTION 31 0.0019
492 HEPATIC LESION 8 0.0018
493 HERPES SIMPLEX 12 0.0018
494 ACUTE KIDNEY INJURY 281 0.0018
495 HEMIPARESIS 31 0.0018
496 HYPERKALAEMIA 64 0.0018
497 RENAL DISORDER 85 0.0018
498 CIRCULATORY COLLAPSE 31 0.0018
499 DYSSTASIA 53 0.0018
500 SUICIDAL IDEATION 166 0.0018
501 BONE DISORDER 33 0.0018
502 PURPURA 16 0.0018
503 ELECTROLYTE IMBALANCE 21 0.0018
504 HEMIPLEGIA 15 0.0018
505 BLOOD CHOLESTEROL INCREASED 84 0.0018
506 DERMATITIS EXFOLIATIVE 9 0.0018
507 LEUKOPENIA 89 0.0018
508 EOSINOPHILIA 31 0.0018
509 MITRAL VALVE INCOMPETENCE 20 0.0018
510 TOOTH FRACTURE 19 0.0017
511 APLASTIC ANAEMIA 9 0.0017
512 WHEEZING 102 0.0017
513 GENERAL PHYSICAL HEALTH DETERIORATION 198 0.0017
514 HYPERTHERMIA 13 0.0017
515 LUNG INFILTRATION 15 0.0017
516 ATRIOVENTRICULAR BLOCK 13 0.0017
517 CONVULSION 96 0.0017
518 DYSPHAGIA 159 0.0017
519 GASTRITIS 44 0.0017
520 LOWER LIMB FRACTURE 32 0.0017
521 BRADYCARDIA 88 0.0017
522 CHROMATURIA 37 0.0016
523 TRICUSPID VALVE INCOMPETENCE 13 0.0016
524 DRUG ABUSER 10 0.0016
525 DRUG-INDUCED LIVER INJURY 51 0.0016
526 DIALYSIS 23 0.0016
527 MYOPATHY 14 0.0016
528 HYPONATRAEMIA 91 0.0016
529 ABDOMINAL TENDERNESS 8 0.0016
530 NERVOUS SYSTEM DISORDER 50 0.0016
531 STATUS EPILEPTICUS 18 0.0016
532 NEUROLOGICAL SYMPTOM 9 0.0016
533 MOTOR DYSFUNCTION 16 0.0016
534 HIP ARTHROPLASTY 24 0.0016
535 ENTEROCOLITIS 9 0.0016
536 GASTROOESOPHAGEAL REFLUX DISEASE 125 0.0016
537 VENTRICULAR EXTRASYSTOLES 16 0.0015
538 REFUSAL OF TREATMENT BY PATIENT 10 0.0015
539 STEVENS-JOHNSON SYNDROME 34 0.0015
540 PYREXIA 526 0.0015
541 UROSEPSIS 14 0.0015
542 VOMITING 712 0.0015
543 PNEUMOTHORAX 24 0.0015
544 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
545 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
546 INTENTIONAL PRODUCT USE ISSUE 132 0.0015
547 BLOOD PRESSURE INADEQUATELY CONTROLLED 9 0.0015
548 OEDEMA PERIPHERAL 182 0.0015
549 COMPRESSION FRACTURE 8 0.0015
550 CARDIOMYOPATHY 22 0.0015
551 ARTERIOSCLEROSIS 14 0.0015
552 SPINAL OSTEOARTHRITIS 13 0.0015
553 TUMOUR LYSIS SYNDROME 13 0.0015
554 IMMUNODEFICIENCY 22 0.0015
555 SUBDURAL HAEMATOMA 21 0.0015
556 ENCEPHALOPATHY 36 0.0015
557 CARDIOMEGALY 18 0.0015
558 NEPHROLITHIASIS 67 0.0015
559 ACUTE CORONARY SYNDROME 12 0.0014
560 HAEMODYNAMIC INSTABILITY 11 0.0014
561 PULMONARY HYPERTENSION 30 0.0014
562 BRAIN OEDEMA 18 0.0014
563 SINUS TACHYCARDIA 20 0.0014
564 THROMBOCYTOPENIA 157 0.0014
565 PNEUMOCYSTIS JIROVECII PNEUMONIA 14 0.0014
566 CORONARY ARTERY DISEASE 42 0.0014
567 SEPTIC SHOCK 60 0.0014
568 ATRIAL FLUTTER 11 0.0014
569 HYPOCALCAEMIA 26 0.0014
570 UTERINE LEIOMYOMA 10 0.0014
571 FACE OEDEMA 23 0.0014
572 ACUTE MYOCARDIAL INFARCTION 40 0.0014
573 UPPER LIMB FRACTURE 27 0.0014
574 CARDIAC FAILURE ACUTE 9 0.0013
575 SINUS BRADYCARDIA 13 0.0013
576 POST-TRAUMATIC STRESS DISORDER 9 0.0013
577 MUSCLE ATROPHY 17 0.0013
578 MALNUTRITION 15 0.0013
579 HAEMORRHAGE INTRACRANIAL 20 0.0013
580 HYPOXIA 47 0.0013
581 GASTROINTESTINAL DISORDER 119 0.0013
582 OPTIC NEURITIS 12 0.0013
583 C-REACTIVE PROTEIN INCREASED 48 0.0013
584 PNEUMONIA 426 0.0013
585 ECCHYMOSIS 9 0.0013
586 HYPERTHYROIDISM 19 0.0013
587 JOINT EFFUSION 9 0.0013
588 IRON DEFICIENCY ANAEMIA 12 0.0013
589 SPINAL FRACTURE 26 0.0013
590 EXTRASYSTOLES 9 0.0013
591 RASH GENERALISED 33 0.0013
592 IMPAIRED WORK ABILITY 27 0.0013
593 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
594 ACUTE HEPATIC FAILURE 17 0.0012
595 SKIN LESION 34 0.0012
596 DIABETES MELLITUS 94 0.0012
597 INTERNATIONAL NORMALISED RATIO INCREASED 35 0.0012
598 LABORATORY TEST ABNORMAL 36 0.0012
599 FEELING DRUNK 9 0.0012
600 DIARRHOEA 774 0.0012
601 ABDOMINAL PAIN 276 0.0012
602 DRUG ERUPTION 21 0.0012
603 ERYTHEMA MULTIFORME 11 0.0012
604 SUBARACHNOID HAEMORRHAGE 12 0.0012
605 DIARRHOEA HAEMORRHAGIC 11 0.0012
606 PSEUDOMONAS INFECTION 10 0.0012
607 RESPIRATORY FAILURE 85 0.0012
608 OEDEMA 63 0.0012
609 SEPSIS 129 0.0012
610 LARGE INTESTINE PERFORATION 8 0.0012
611 PULMONARY HAEMORRHAGE 9 0.0011
612 ABDOMINAL DISTENSION 120 0.0011
613 EPILEPSY 35 0.0011
614 URINE OUTPUT DECREASED 10 0.0011
615 RESPIRATORY DISORDER 34 0.0011
616 HALLUCINATION, AUDITORY 18 0.0011
617 MULTIPLE ORGAN DYSFUNCTION SYNDROME 32 0.0011
618 ABSCESS 18 0.0011
619 PAIN 692 0.0011
620 HYPERGLYCAEMIA 41 0.0011
621 CANDIDA INFECTION 19 0.0011
622 HIP FRACTURE 36 0.0011
623 VASCULITIS 13 0.0011
624 BIPOLAR DISORDER 12 0.0011
625 NEUROPATHY PERIPHERAL 104 0.0011
626 HAEMOGLOBIN DECREASED 112 0.0011
627 SHOCK 25 0.0011
628 EOSINOPHIL COUNT INCREASED 9 0.0011
629 NERVE INJURY 12 0.0011
630 POLLAKIURIA 45 0.0011
631 APPENDICITIS 10 0.0011
632 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
633 GASTRIC ULCER 20 0.0011
634 GENERALISED OEDEMA 13 0.0010
635 DEHYDRATION 140 0.0010
636 DIFFUSE LARGE B-CELL LYMPHOMA 8 0.0010
637 DERMATITIS ALLERGIC 13 0.0010
638 STAPHYLOCOCCAL INFECTION 34 0.0010
639 NEUTROPENIA 140 0.0010
640 CORONARY ARTERY OCCLUSION 14 0.0010
641 ARTERIAL OCCLUSIVE DISEASE 8 0.0010
642 CYANOSIS 16 0.0010
643 RESPIRATORY RATE INCREASED 9 0.0010
644 DEPRESSED LEVEL OF CONSCIOUSNESS 40 0.0010
645 WEIGHT DECREASED 281 0.0010
646 HIATUS HERNIA 13 0.0010
647 OVARIAN CYST 10 0.0010
648 NAUSEA 791 0.0010
649 LEUKOCYTOSIS 18 0.0010
650 PALLOR 27 0.0010
651 INTERSTITIAL LUNG DISEASE 48 0.0010
652 PARALYSIS 14 0.0010
653 CONDITION AGGRAVATED 297 0.0010
654 MOBILITY DECREASED 70 0.0010
655 CYST 12 0.0010
656 ILEUS 12 0.0010
657 APHASIA 29 0.0010
658 FLANK PAIN 9 0.0010
659 SQUAMOUS CELL CARCINOMA 9 0.0010
660 EYELID OEDEMA 11 0.0009
661 CEREBRAL INFARCTION 23 0.0009
662 ACUTE RESPIRATORY FAILURE 18 0.0009
663 COORDINATION ABNORMAL 13 0.0009
664 OSTEOARTHRITIS 39 0.0009
665 ASPIRATION 10 0.0009
666 HAEMATEMESIS 23 0.0009
667 CARDIOGENIC SHOCK 13 0.0009
668 MYALGIA 154 0.0009
669 VERTIGO 55 0.0009
670 BLOOD POTASSIUM DECREASED 27 0.0009
671 LIVER INJURY 22 0.0009
672 BLOOD UREA INCREASED 15 0.0009
673 JOINT RANGE OF MOTION DECREASED 12 0.0009
674 ASTHENIA 333 0.0009
675 BODY TEMPERATURE INCREASED 18 0.0009
676 RED BLOOD CELL COUNT DECREASED 25 0.0009
677 HEPATIC CANCER 21 0.0009
678 UNEVALUABLE EVENT 66 0.0009
679 HERPES ZOSTER 50 0.0009
680 DYSURIA 32 0.0009
681 PERICARDIAL EFFUSION 20 0.0009
682 MENTAL STATUS CHANGES 24 0.0009
683 COMA 41 0.0009
684 BACTERIAL INFECTION 16 0.0009
685 DYSARTHRIA 32 0.0008
686 MEDICATION ERROR 47 0.0008
687 NEUROLEPTIC MALIGNANT SYNDROME 10 0.0008
688 ATAXIA 10 0.0008
689 THIRST 15 0.0008
690 CEREBRAL HAEMORRHAGE 30 0.0008
691 ACUTE MYELOID LEUKAEMIA 13 0.0008
692 ABNORMAL DREAMS 23 0.0008
693 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
694 HYPOPHAGIA 21 0.0008
695 LUNG DISORDER 40 0.0008
696 SCIATICA 13 0.0008
697 INFLAMMATION 42 0.0008
698 BODY TEMPERATURE DECREASED 8 0.0008
699 CONJUNCTIVITIS 15 0.0008
700 SUICIDE ATTEMPT 49 0.0008
701 DISORIENTATION 32 0.0008
702 GINGIVAL BLEEDING 11 0.0008
703 BLOOD POTASSIUM INCREASED 13 0.0008
704 PNEUMONIA ASPIRATION 20 0.0008
705 EATING DISORDER 17 0.0008
706 OFF LABEL USE 695 0.0008
707 HYPOTHERMIA 8 0.0008
708 MANIA 13 0.0008
709 PRURITUS GENERALISED 17 0.0008
710 DRUG LEVEL DECREASED 8 0.0008
711 BONE PAIN 46 0.0008
712 MYOCARDITIS 9 0.0008
713 DRUG DISPENSING ERROR 12 0.0008
714 MENTAL DISORDER 34 0.0008
715 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
716 PLATELET COUNT DECREASED 82 0.0008
717 CARDIO-RESPIRATORY ARREST 32 0.0008
718 MUCOSAL INFLAMMATION 20 0.0008
719 IMMUNE SYSTEM DISORDER 10 0.0008
720 SENSORY DISTURBANCE 12 0.0007
721 HYPERTENSION 158 0.0007
722 LIVER FUNCTION TEST INCREASED 16 0.0007
723 NOCTURIA 9 0.0007
724 PRODUCT USE IN UNAPPROVED INDICATION 182 0.0007
725 MYOCARDIAL INFARCTION 128 0.0007
726 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
727 GASTROINTESTINAL PAIN 8 0.0007
728 RESPIRATORY ARREST 20 0.0007
729 NIGHTMARE 25 0.0007
730 PULMONARY OEDEMA 32 0.0007
731 TYPE 2 DIABETES MELLITUS 24 0.0007
732 MOUTH ULCERATION 15 0.0007
733 BLINDNESS UNILATERAL 10 0.0007
734 FEAR 19 0.0007
735 HAEMATOCRIT DECREASED 14 0.0007
736 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
737 OBESITY 11 0.0007
738 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
739 APATHY 10 0.0007
740 PULMONARY EMBOLISM 65 0.0007
741 ACCIDENTAL OVERDOSE 25 0.0007
742 BACTERAEMIA 8 0.0007
743 CARDIAC FAILURE 54 0.0007
744 PRODUCTIVE COUGH 32 0.0007
745 TACHYCARDIA 59 0.0007
746 DYSPNOEA EXERTIONAL 25 0.0007
747 GAIT DISTURBANCE 127 0.0007
748 UVEITIS 9 0.0007
749 HALLUCINATION 50 0.0007
750 DRUG ADMINISTRATION ERROR 20 0.0007
751 CONFUSIONAL STATE 104 0.0006
752 CHILLS 75 0.0006
753 BLOOD SODIUM DECREASED 12 0.0006
754 ABDOMINAL PAIN LOWER 16 0.0006
755 VISUAL ACUITY REDUCED 21 0.0006
756 ATRIAL FIBRILLATION 61 0.0006
757 RASH PAPULAR 14 0.0006
758 PLEURAL EFFUSION 38 0.0006
759 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
760 FEMUR FRACTURE 19 0.0006
761 ARRHYTHMIA 29 0.0006
762 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
763 ABNORMAL BEHAVIOUR 24 0.0006
764 CARDIAC ARREST 50 0.0006
765 VENTRICULAR TACHYCARDIA 10 0.0006
766 PSYCHOMOTOR HYPERACTIVITY 10 0.0006
767 HYPERSENSITIVITY 111 0.0006
768 HYPOAESTHESIA ORAL 9 0.0006
769 HYPOTHYROIDISM 19 0.0006
770 EJECTION FRACTION DECREASED 9 0.0006
771 DECREASED APPETITE 134 0.0006
772 VAGINAL HAEMORRHAGE 25 0.0006
773 HYPOMAGNESAEMIA 8 0.0006
774 DERMATITIS 12 0.0006
775 MASS 8 0.0006
776 NEUROTOXICITY 10 0.0006
777 BACK PAIN 132 0.0006
778 ABASIA 14 0.0006
779 KIDNEY INFECTION 11 0.0006
780 HYPOGLYCAEMIA 27 0.0006
781 ANOSMIA 8 0.0006
782 INSOMNIA 147 0.0006
783 ROAD TRAFFIC ACCIDENT 23 0.0005
784 DEPRESSED MOOD 29 0.0005
785 MELAENA 12 0.0005
786 INTENTIONAL SELF-INJURY 11 0.0005
787 FEBRILE NEUTROPENIA 36 0.0005
788 BLOOD GLUCOSE ABNORMAL 10 0.0005
789 DRUG ABUSE 45 0.0005
790 SKIN DISORDER 18 0.0005
791 SPEECH DISORDER 28 0.0005
792 METRORRHAGIA 9 0.0005
793 NIGHT SWEATS 17 0.0005
794 SCAR 9 0.0005
795 MUSCULOSKELETAL DISORDER 10 0.0005
796 DELIRIUM 18 0.0005
797 CHEST PAIN 96 0.0005
798 AGITATION 38 0.0005
799 LUNG INFECTION 8 0.0005
800 HAEMORRHOIDS 10 0.0005
801 FAECES DISCOLOURED 11 0.0005
802 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
803 PALPITATIONS 59 0.0005
804 GOUT 9 0.0005
805 DISTURBANCE IN ATTENTION 27 0.0005
806 HYPOAESTHESIA 74 0.0005
807 PRESYNCOPE 12 0.0005
808 RASH 213 0.0005
809 LETHARGY 28 0.0005
810 EYE DISORDER 16 0.0005
811 DYSGEUSIA 36 0.0005
812 PERITONITIS 10 0.0005
813 RASH PRURITIC 26 0.0005
814 PAIN IN EXTREMITY 141 0.0005
815 ABDOMINAL PAIN UPPER 98 0.0005
816 COLITIS 18 0.0005
817 SLEEP APNOEA SYNDROME 9 0.0005
818 HYPOTENSION 94 0.0005
819 SOMNOLENCE 94 0.0005
820 GASTRIC DISORDER 16 0.0005
821 DYSTONIA 9 0.0005
822 AMNESIA 30 0.0005
823 RESPIRATORY TRACT INFECTION 12 0.0005
824 MALAISE 202 0.0005
825 DISABILITY 9 0.0005
826 SYNCOPE 45 0.0004
827 GALLBLADDER DISORDER 8 0.0004
828 ILL-DEFINED DISORDER 27 0.0004
829 BLINDNESS 18 0.0004
830 URINARY INCONTINENCE 13 0.0004
831 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
832 SKIN DISCOLOURATION 20 0.0004
833 BRONCHITIS 32 0.0004
834 FATIGUE 336 0.0004
835 ERECTILE DYSFUNCTION 11 0.0004
836 PARAESTHESIA 67 0.0004
837 SLEEP DISORDER 30 0.0004
838 ARTHRALGIA 176 0.0004
839 FLATULENCE 24 0.0004
840 MEMORY IMPAIRMENT 58 0.0004
841 LOSS OF CONSCIOUSNESS 54 0.0004
842 INFECTION 61 0.0004
843 DEAFNESS 11 0.0004
844 AGGRESSION 21 0.0004
845 RECTAL HAEMORRHAGE 18 0.0004
846 DRUG PRESCRIBING ERROR 8 0.0004
847 SWELLING FACE 27 0.0004
848 TINNITUS 19 0.0004
849 MUSCULAR WEAKNESS 47 0.0004
850 DYSPNOEA 234 0.0004
851 HEADACHE 259 0.0004
852 ADVERSE DRUG REACTION 37 0.0004
853 THROMBOSIS 33 0.0004
854 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
855 DIZZINESS 202 0.0004
856 TOOTH DISORDER 9 0.0004
857 DEEP VEIN THROMBOSIS 26 0.0004
858 TREATMENT FAILURE 33 0.0004
859 HAEMOPTYSIS 11 0.0004
860 DRUG INTOLERANCE 38 0.0004
861 OXYGEN SATURATION DECREASED 22 0.0004
862 COUGH 109 0.0004
863 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
864 DISEASE RECURRENCE 18 0.0004
865 CELLULITIS 19 0.0004
866 MOVEMENT DISORDER 12 0.0004
867 CARDIAC FAILURE CONGESTIVE 30 0.0004
868 CEREBROVASCULAR ACCIDENT 63 0.0004
869 ASTHMA 42 0.0004
870 HEART RATE DECREASED 13 0.0004
871 NEURALGIA 9 0.0004
872 NEUTROPHIL COUNT DECREASED 15 0.0004
873 COGNITIVE DISORDER 17 0.0004
874 AGEUSIA 9 0.0004
875 WEIGHT INCREASED 80 0.0004
876 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
877 THROAT IRRITATION 16 0.0004
878 BLISTER 20 0.0004
879 RHINORRHOEA 23 0.0004
880 OVERDOSE 76 0.0004
881 PRURITUS 135 0.0004
882 SKIN ULCER 9 0.0003
883 HAEMATOMA 9 0.0003
884 BLOOD PRESSURE DECREASED 23 0.0003
885 CYSTITIS 11 0.0003
886 NEOPLASM PROGRESSION 12 0.0003
887 ARTHRITIS 27 0.0003
888 TOXICITY TO VARIOUS AGENTS 57 0.0003
889 COVID-19 59 0.0003
890 DYSPEPSIA 33 0.0003
891 RASH ERYTHEMATOUS 16 0.0003
892 IRRITABILITY 20 0.0003
893 VIRAL INFECTION 11 0.0003
894 CRYING 12 0.0003
895 MENTAL IMPAIRMENT 8 0.0003
896 MOOD ALTERED 9 0.0003
897 ABDOMINAL DISCOMFORT 55 0.0003
898 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
899 HYPERHIDROSIS 42 0.0003
900 ANGER 11 0.0003
901 NASAL CONGESTION 19 0.0003
902 URINARY TRACT INFECTION 55 0.0003
903 SEIZURE 37 0.0003
904 INJECTION SITE REACTION 22 0.0003
905 BLOOD GLUCOSE INCREASED 60 0.0003
906 CARDIOVASCULAR DISORDER 8 0.0003
907 RASH MACULAR 11 0.0003
908 DRUG DOSE OMISSION 52 0.0003
909 JOINT STIFFNESS 8 0.0003
910 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
911 BALANCE DISORDER 26 0.0003
912 GAIT INABILITY 10 0.0003
913 OCULAR HYPERAEMIA 14 0.0003
914 LIMB INJURY 8 0.0003
915 CHEST DISCOMFORT 30 0.0003
916 EMOTIONAL DISORDER 9 0.0003
917 DEATH 251 0.0003
918 TREMOR 48 0.0003
919 CARDIAC DISORDER 27 0.0003
920 FALL 94 0.0003
921 ANGINA PECTORIS 8 0.0003
922 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
923 PANIC ATTACK 10 0.0003
924 SKIN EXFOLIATION 23 0.0003
925 INJURY 19 0.0003
926 URINARY RETENTION 9 0.0003
927 EYE SWELLING 10 0.0003
928 NECK PAIN 15 0.0003
929 MUSCULOSKELETAL PAIN 14 0.0003
930 VISION BLURRED 36 0.0003
931 URTICARIA 43 0.0003
932 HOSPITALISATION 39 0.0003
933 HEART RATE INCREASED 25 0.0003
934 MUSCLE SPASMS 46 0.0003
935 ECZEMA 13 0.0002
936 RESTLESSNESS 9 0.0002
937 THERAPY NON-RESPONDER 11 0.0002
938 FEELING HOT 15 0.0002
939 IMPAIRED HEALING 8 0.0002
940 COMPLETED SUICIDE 20 0.0002
941 NERVOUSNESS 12 0.0002
942 BURNING SENSATION 16 0.0002
943 VISUAL IMPAIRMENT 28 0.0002
944 SINUSITIS 23 0.0002
945 HAEMORRHAGE 23 0.0002
946 ARTHROPATHY 12 0.0002
947 EPISTAXIS 16 0.0002
948 INTESTINAL OBSTRUCTION 8 0.0002
949 CONSTIPATION 46 0.0002
950 NEOPLASM MALIGNANT 14 0.0002
951 HYPOACUSIS 9 0.0002
952 ERYTHEMA 42 0.0002
953 COLITIS ULCERATIVE 9 0.0002
954 STOMATITIS 12 0.0002
955 INFLUENZA 22 0.0002
956 BLOOD PRESSURE INCREASED 30 0.0002
957 EYE PAIN 11 0.0002
958 INFLUENZA LIKE ILLNESS 16 0.0002
959 MUSCULOSKELETAL STIFFNESS 16 0.0002
960 HOT FLUSH 13 0.0002
961 SURGERY 10 0.0002
962 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
963 CATARACT 10 0.0002
964 NASOPHARYNGITIS 30 0.0002
965 DRUG INEFFECTIVE 214 0.0002
966 FEELING ABNORMAL 38 0.0002
967 FLUID RETENTION 8 0.0002
968 DYSPHONIA 9 0.0002
969 DRY SKIN 20 0.0001
970 INJECTION SITE PRURITUS 10 0.0001
971 THERAPEUTIC RESPONSE DECREASED 9 0.0001
972 HAEMATOCHEZIA 8 0.0001
973 ADVERSE EVENT 13 0.0001
974 INTENTIONAL PRODUCT MISUSE 12 0.0001
975 JOINT SWELLING 16 0.0001
976 ACNE 10 0.0001
977 INCORRECT DOSE ADMINISTERED 30 0.0001
978 SWELLING 12 0.0001
979 DISEASE PROGRESSION 15 0.0001
980 INTENTIONAL OVERDOSE 8 0.0001
981 PERIPHERAL SWELLING 19 0.0001
982 DRY MOUTH 10 0.0001
983 PRODUCT USE ISSUE 23 0.0001
984 OROPHARYNGEAL PAIN 11 0.0001
985 CONTUSION 11 0.0001
986 ALOPECIA 22 0.0001
987 PROSTATE CANCER 9 0.0001
988 DRUG WITHDRAWAL SYNDROME 8 0.0001
989 FLUSHING 8 0.0001
990 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
991 NO ADVERSE EVENT 12 0.0001
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
993 INJECTION SITE PAIN 17 0.0001